The discovery of novel chemistry for fungal control demonstrates digital technologies reduce the time needed for R&D discovery, while building in safety guardrails early
BASEL, Switzerland & MYSTIC, Conn. -- Business Wire --Syngenta Crop Protection, a global leader in agricultural innovation, and crop health company Enko announced today the discovery of novel chemistry to control fungal disease in crops, using a platform that reduces the time required for R&D discovery.
The new chemistry features a new mode of action designed to target diseases that can devastate cereal crops. This breakthrough was achieved by screening billions of chemical molecules within Enko’s DNA-encoded libraries, and then using artificial intelligence and machine learning models to identify potent, selective molecules. This significantly shortens the time required for the discovery process, while ensuring molecules meet specified safety criteria.
Fungal pathogens are a major challenge to the health of crops worldwide. Diseases caused by these pathogens alone cause growers to lose between 10-23 percent of their yield; for the top 5 staple crops – rice, wheat, corn, soybeans and potatoes – this is estimated to be enough to feed as much as 4 billion people a daily diet of 2,000 calories for a whole year. Experts predict such losses will worsen with global warming widening the spread of fungal infections, as well as rising resistance to existing fungicides.
The fungicide discovery milestone is part of Syngenta and Enko’s multi-year collaboration to bring new, affordable, safe and sustainable crop protection solutions to farmers globally. The companies have now entered into the next phase of their collaboration, to optimize the fungicide’s attributes and rigorously test them for safety and efficacy. The two companies further aim to build on the success of the fungicide collaboration, and have signed a new agreement to discover novel chemical starting points for a new herbicide.
“We are excited to partner with Enko to apply the latest in drug discovery and development approaches used in the pharmaceutical industry to agriculture, and to be able to bring new and effective agricultural solutions even more quickly to farmers,” said Camilla Corsi, Global Head of Research at Syngenta Crop Protection. “With a new mode of action, this novel chemistry promises to help farmers sustainably manage crops, protect yields, and combat resistance.”
“The world faces a food security crisis that climate change is steadily worsening,” said Enko CEO and founder Jacqueline Heard. “By proving that digital tools can cut discovery time for new crop protection solutions, we hope to accelerate the digital transformation shift within the agricultural industry as growers' needs become more urgent."
With its newest collaboration, Enko and Syngenta will focus on discovering herbicide solutions to combat widespread resistance and eliminate aggressive weeds, such as Palmer Amaranth.
About Syngenta Crop Protection
Syngenta Crop Protection is a leader in agricultural innovation, bringing breakthrough technologies and solutions that enable farmers to grow productively and sustainably. We offer a leading portfolio of crop protection solutions for plant and soil health, as well as digital solutions that transform the decision-making capabilities of farmers. Our 17,900 employees serve to advance agriculture in more than 90 countries around the world. Syngenta Crop Protection is headquartered in Basel, Switzerland, and is part of the Syngenta Group. Follow us on Twitter at www.twitter.com/Syngenta, www.twitter.com/SyngentaUS and on LinkedIn at www.linkedin.com/company/syngenta.
Enko (Enko Chem Inc.) designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017, and led by a team of proven scientists, entrepreneurs, and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Nufarm, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko is headquartered in Mystic, Connecticut, USA. For more information, visit www.enko.ag
Syngenta’s Cautionary Statement Regarding Forward-Looking Statements
This document may contain forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.
©2024 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland
Enko’s Cautionary Statement Regarding Forward-Looking Statements
This press release contains forecasts, projections, goals, plans, and other forward-looking statements. Such forward-looking statements are based on Enko's assumptions, estimates, outlook, and other judgments made in light of information available at the time of preparation of such statements and involve both known and unknown risks and uncertainties. Accordingly, plans, goals, and other statements may not be realized as described, and actual financial results, success/failure or progress of development, and other projections may differ materially from those presented herein. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Enko’s control and that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Enko does not intend to update any forward-looking statements appearing herein in the event of changing circumstances or otherwise, and such statements are current only as of the date they are made.
©Enko. 62 Maritime Drive, Mystic, CT 06355 USA